These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1854464)

  • 21. Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
    Delacrétaz E; Nussberger J; Biollaz J; Waeber B; Brunner HR
    Hypertension; 1995 Jan; 25(1):14-21. PubMed ID: 7843746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
    De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
    Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects.
    Nakashima M; Uematsu T; Kosuge K; Kanamaru M
    Eur J Clin Pharmacol; 1992; 42(3):333-5. PubMed ID: 1577054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive PH dogs.
    Bovee KC; Wong PC; Timmermans PB; Thoolen MJ
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):327S-333S. PubMed ID: 1854460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
    Osei SY; Minkes RK; Bellan JA; Kadowitz PJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1104-12. PubMed ID: 8450454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
    Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
    J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis.
    Jaiswal N; Diz DI; Tallant EA; Khosla MC; Ferrario CM
    Am J Hypertens; 1991 Mar; 4(3 Pt 1):228-33. PubMed ID: 2043299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.
    Kaiser FC; Palmer GC; Wallace AV; Carr RD; Fraser-Rae L; Hallam C
    Neuroreport; 1992 Oct; 3(10):922-4. PubMed ID: 1358253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
    Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
    Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of DuP 753 and EXP3174 on responses to angiotensin II in pulmonary vascular bed of the cat.
    McMahon TJ; Kaye AD; Hood JS; Minkes RK; Nossaman BD; Kadowitz PJ
    J Appl Physiol (1985); 1992 Nov; 73(5):2054-61. PubMed ID: 1474085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of the renin-angiotensin system on the sympathetic response induced by the cold pressor test in humans].
    Zavala LE; Cierco M; Gutiérrez A; Garrido MR; Israel A
    Invest Clin; 2007 Jun; 48(2):155-65. PubMed ID: 17598639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.